This is a synthetic peptide designed for use in combination with anti-LOH11CR2A Antibody(ARP55093_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
限制
仅限研究用
状态
Lyophilized
溶解方式
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
浓度
1 mg/mL
缓冲液
Final peptide concentration is 1 mg/mL in PBS.
注意事项
Avoid repeated freeze-thaw cycles.
储存条件
-20 °C
储存方法
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
抗原
VWA5A
(Von Willebrand Factor A Domain Containing 5A (VWA5A))
别名
VWA5A Peptide, LOH11CR2A Peptide, MGC68953 Peptide, loh11cr2a Peptide, BCSC-1 Peptide, BCSC1 Peptide, 5830475I06Rik Peptide, AW552491 Peptide, E130119J22 Peptide, Loh11cr2a Peptide, masa-1 Peptide, loss of heterozygosity, 11, chromosomal region 2, gene A Peptide, von Willebrand factor A domain containing 5A Peptide, von Willebrand factor A domain containing 5A S homeolog Peptide, LOH11CR2A Peptide, VWA5A Peptide, vwa5a.S Peptide, vwa5a Peptide, Vwa5a Peptide
背景
LOH11CR2A may play a role in tumorigenesis as a tumor suppressor. Altered expression of this protein and disruption of the molecular pathway it is involved in, may contribute directly to or modify tumorigenesis.